Clinical Trial

Platelet Transfusion and Repeat TEG-PM in Patients With Severe TBI on Antiplatelet Therapy (Repeat TEG-PM)

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The aim of this study is to see if administering platelets (cells in our blood that stop or prevent bleeding) results in improved platelet function and slows/stops the progression of a head bleed for patients who have a traumatic head bleed and are on antiplatelet therapy (medications that stop blood cells from forming a blood clot) prior to admission.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-05-28; most recent amendment 2025-10-27.
Trial Details
NCT Number NCT06433622
Lead Sponsor Lancaster General Hospital
Conditions Traumatic Intracranial Hemorrhage
Enrollment 225 participants
Start Date 2023-12-01
Primary Completion 2026-12 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2025-10-29